Press Releases

These are press releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Sign up for Email Alerts

Year All Years 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 Category All Categories Brachytherapy Corporate and Financial Releases Oncology Proton Therapy Radiosurgery Security and Inspection X-Ray Products Uncategorized Keywords Go

Advanced Search

Search

  Search Headlines Only

Category

All Categories Brachytherapy Corporate and Financial Releases Oncology Proton Therapy Radiosurgery Security and Inspection X-Ray Products Uncategorized

From

To

Asset Types

 Video  Audio  Photos  Documents  Events  Standard

 Basic Search

• Mar 17, 2020

  Alabama's Only Proton Therapy Center Treats First Patient with Varian ProBeam
• Mar 16, 2020

  Varian to Equip New Ethos Personalized Adaptive Therapy Center in Phoenix
• Mar 16, 2020

  Varian Halcyon 2.0 Treatment System Receives China NMPA Approval
• Mar 11, 2020

  Quebec Selects Varian to Increase Access to Advanced Cancer Care
• Mar 10, 2020

  Ethos Therapy Continues Global Expansion

  First treatments completed in Australia and The Netherlands
• Mar 9, 2020

  Varian Provides an Update on Expected Impact From COVID-19
• Feb 27, 2020

  Varian to Attend Upcoming Investor Events
• Feb 11, 2020

  Varian Receives FDA 510(k) Clearance for Ethos Therapy

  Ethos represents a new chapter in democratized cancer care
• Jan 29, 2020

  Massachusetts General Hospital Selects Varian Radiotherapy Systems for Cancer Center
• Jan 29, 2020

  Varian Reports Results for First Quarter of Fiscal Year 2020
• Jan 20, 2020

  Varian Appoints Prof. Dr. Ricky Sharma VP of Clinical Affairs
• Dec 30, 2019

  Varian to Present at the J.P. Morgan Healthcare Conference
• Dec 18, 2019

  Varian Announces First Quarter Fiscal Year 2020 Earnings Release Date
• Dec 5, 2019

  Varian Schedules Annual Stockholder Meeting in Palo Alto
• Dec 3, 2019

  Varian Further Expands Access to Care in Africa to Address Growing Cancer Burden
• Nov 27, 2019

  Dr. Michelle Le Beau Named to Varian Board of Directors
• Nov 25, 2019

  Varian to Attend Upcoming Investor Events
• Nov 22, 2019

  Varian Updates GAAP Results for Fourth Quarter and Full Fiscal Year 2019
• Nov 18, 2019

  First Cancer Patient Treated with Varian ProBeam Compact Proton Therapy System at Treatment Center in Florida
• Nov 13, 2019

  Varian Named One of America's Most Just Companies in 2019 by Forbes and JUST Capital
• Nov 6, 2019

  Varian Selected by Michigan Oncology Quality Consortium to Support Transition to Value-Based Care

  Key Highlights
• Oct 30, 2019

  Icon Group Expands Cancer Care Capabilities with Purchase of Varian Adaptive Therapy Solution
• Oct 29, 2019

  Varian Names Anshul Maheshwari Vice President Investor Relations
• Oct 24, 2019

  Varian ProBeam 360 System Selected by The Ohio State University for New Proton Therapy Center
• Oct 23, 2019

  Varian ProBeam 360 Proton Therapy System Selected by Penn Medicine for Use in Second Treatment Center

  Varian proton therapy systems to now be installed in two Penn Medicine centers
• Oct 23, 2019

  Varian Receives Order for Six Ethos Therapy Solutions from Amsterdam UMC in The Netherlands
• Oct 23, 2019

  Varian Reports Results for Fourth Quarter and Full Fiscal Year 2019; Appoints New President of Interventional Oncology Solutions and New Chief Financial Officer
• Oct 14, 2019

  Varian and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center Achieve Significant Milestone in Research of FLASH Therapy
• Oct 8, 2019

  Varian Highlights Interventional Oncology Solutions at CIO Symposium
• Sep 23, 2019

  Varian U.S. Tariff Exclusion Request Granted for Radiotherapy System Components
• Sep 16, 2019

  Varian Names Chief Medical Officer for Interventional Oncology

  Francis R. Facchini, M.D., FSIR, fills new role for interventional oncology globally
• Sep 16, 2019

  Varian Ranked Highest in Survey of US Radiation Oncology Professionals

  Company Ranked Highest in Eight Key Performance Areas and Net Promotor Score
• Sep 16, 2019

  Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System
• Sep 15, 2019

  Varian Unveils Innovative New Solution for Adaptive Therapy

  Key Highlights
• Sep 13, 2019

  Varian and Oncora Partner to Accelerate Precision Medicine in Radiation Oncology
• Sep 12, 2019

  Varian Announces Fourth Quarter Fiscal Year 2019 Earnings Release Date
• Sep 11, 2019

  Varian Expects to Benefit from Linear Accelerator Tariff Exclusion in China
• Sep 10, 2019

  Varian-equipped New York Proton Therapy Center Treats First Patients
• Aug 28, 2019

  Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at Sylvester Comprehensive Cancer Center
• Aug 21, 2019

  Dr. Phil Febbo Named to Varian Board of Directors
• Aug 21, 2019

  Varian Completes Purchase of Embolic Bead Asset
• Aug 19, 2019

  Varian to Hold Investor Day in New York City
• Aug 8, 2019

  Varian Updates Investors on Proposed Reimbursement Changes
• Aug 8, 2019

  Varian to Host Investor Meeting at ASTRO in Chicago
• Aug 5, 2019

  Varian Announces Immaterial Impact of Newly Proposed Tariffs
• Jul 29, 2019

  Three Radiotherapy Centers in Serbia Standardize on Varian Solution for Cancer Treatment Planning
• Jul 25, 2019

  Karolinska University Hospital Solna Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System
• Jul 24, 2019

  Varian Reports Results for Third Quarter of Fiscal Year 2019
• Jul 11, 2019

  Varian to Showcase Cancer Care Systems and Software at AAPM 2019
• Jul 9, 2019

  Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at King Chulalongkorn Memorial Hospital, Bangkok, Thailand

  Her Royal Highness Princess Maha Chakri Sirindhorn Presided Over Rigging Ceremony

Show 5102550100 per page